QIAGEN

Understanding the USCIS tuberculosis testing guidelines - on demand webinar

Responsive image

View a free webinar recording on IGRA testing requirements for civil surgeons

Dummy field DO NOT USE/ DELETE/ MODIFY Needs to be hidden in CSS on LP
Script on LP to collect URL
If Opp Type is INSTRUMENT // For SP creation / could be hidden field
If Opp Type is INSTRUMENT // For SP creation / could be hidden field
For SP creation / could be hidden field
For SP creation / could be hidden field
For SP creation / could be hidden field
For SP creation / could be hidden field
Dr-Kawaruma-Webinar
For SP creation / could be hidden field
For SP creation / could be hidden field
For SP creation / could be hidden field
For SP creation / could be hidden field
For SP creation / could be hidden field









I hereby give QIAGEN the consent to contact me via email and phone (subject to the contact information provided above) with further special offers, contests and product information.

Understanding the USCIS tuberculosis testing guidelines - on demand webinar

The tuberculin skin test (TST) is no longer accepted for USCIS immigration exams. Instead, a TB blood test (interferon-gamma release assay or IGRA) is required for permanent resident applicants ages 2 and older. While an individual with a positive IGRA is able to complete the status adjustment process, LTBI positive results must be reported to the local health department. This CDC/USCIS requirement for IGRA-only testing aligns with current CDC recommendations stating that IGRA testing is strongly preferred for those who are BCG-vaccinated.

Are you and your practice ready? Join Dr. Alowode Oladele to hear more about the IGRA requirement and additional details on the technical instructions. Learn how to interpret and manage IGRA results, and why this requirement is an important step in the CDC’s march toward TB elimination in the US. Dr. Oladele is the medical director of county-wide services for the DeKalb County Board of Health, Georgia, where he directs medical screening of 1,000–2,000 refugees annually.

1. WHO. Latent tuberculosis infection: Updated and consolidated guidelines for programmatic management. WHO/CDS/TB/2018.4

QuantiFERON-TB Gold Plus (QFT-Plus) is an in vitro diagnostic aid for detection of Mycobacterium tuberculosis infection. QFT-Plus is an indirect test for M. tuberculosis infection (including disease) and is intended for use in conjunction with risk assessment, radiography, and other medical and diagnostic evaluations. QFT-Plus Package Inserts as well as up-to- date licensing information and product-specific disclaimers can be found at www.QuantiFERON.com.

+ Subject to your consent given above, QIAGEN may use your personal information for internal business and marketing purposes. The information will not be sold to any third party. QIAGEN may transfer your personal information to our CRM system (hosted by SalesForce.com, Inc. and Oracle Corp.) solely for the purposes of data hosting and QIAGEN email distribution. You may unsubscribe at any time. Your data will be processed in compliance with applicable privacy laws, including the EU General Data Protection Regulation. For further details, please refer to our Privacy Policy.